Most of what we write about on this blog comes with a long list of caveats, “studied mostly in animals,” “human data is thin,” “not approved.” GLP-1 medications are the exception, and it's worth understanding why, because the difference is the whole point.

What GLP-1s actually are

GLP-1 stands for glucagon-like peptide-1, a hormone your body already makes that helps regulate blood sugar and appetite. The medications in this class, semaglutide and tirzepatide being the best known, are engineered to mimic and extend that signal. They are peptides, technically, but unlike the research compounds elsewhere on this site, they've been through the full approval process.

You'll recognize them by their brand names: semaglutide is sold as Ozempic and Rybelsus for type 2 diabetes and as Wegovy for weight management; tirzepatide is sold as Mounjaro for diabetes and Zepbound for weight management.

Why they sit in a different category

This is the part that separates GLP-1s from the rest of the peptide world. They are FDA-approved, supported by large randomized clinical trials, and prescribed every day by licensed clinicians for their approved uses. When a doctor prescribes Wegovy for chronic weight management, that's an on-label, evidence-backed decision, not an experiment.

With most peptides, the honest summary is “promising but unproven.” With FDA-approved GLP-1s, the evidence base is genuinely large. That's a real and important difference.

We still won't print doses or injection instructions here, that's between a person and their prescriber, but we can say plainly that these are established medicines rather than speculative ones.

The part that does require caution

The catch isn't the science, it's the marketplace. When demand outran supply, a wave of “compounded” and “research” GLP-1 products appeared online, often with claims that don't hold up. The FDA has issued warning letters over misleading marketing of compounded versions, including products framed as “generic” equivalents or sold under “research use only” labels while clearly aimed at human use.

A few things worth keeping straight:

  • There is no “generic” Ozempic or Wegovy, the approved products are brand-name only.
  • A “research use only” label on a vial aimed at people is a red flag, not a reassurance.
  • Whether a compounded version is appropriate is a clinical and legal question for a licensed provider, not a checkout button.
Where we fit in

We don't sell medication and we don't prescribe. What we do is connect you with licensed telehealth providers who can determine whether an FDA-approved GLP-1, or another option, is appropriate for you, and who source through legitimate, properly regulated channels. The route matters as much as the molecule.

The bottom line

If you take one thing from this piece: GLP-1 medications are the most evidence-backed, clearly regulated option in the broader peptide conversation, and also the category where shady online sellers are most active. The safe path is the boring one, a licensed provider and an appropriately sourced, approved product. We can help you find the first part.